By Tony Winterburn • Published: 28 Feb 2021 • 6:41
NO AstraZeneca Side-Effects In Spain’s Valencian Community Image: Pixabay
FDA Grants Emergency Use Authorisation For Johnson & Johnson’s 1-Shot COVID-19 Vaccine.
The U.S. Food and Drug Administration on Saturday, Feb. 27, granted emergency-use authorisation of Johnson & Johnson’s one-dose coronavirus vaccine. The vaccine becomes the United States’ third against COVID-19, but the only one that provides enough protection with a single dose. Experts said it could expedite efforts to inoculate the population as virus variants spread.
“The authorisation of this vaccine expands the availability of vaccines, the best medical prevention method for COVID-19, to help us in the fight against this pandemic, which has claimed over half a million lives in the United States,” acting FDA Commissioner Janet Woodcock said in a statement.
“The FDA, through our open and transparent scientific review process, has now authorized three COVID-19 vaccines with the urgency called for during this pandemic, using the agency’s rigorous standards for safety, effectiveness and manufacturing quality needed to support emergency use authorization.”
The Johnson & Johnson vaccine does not have to be kept frozen and there is no need for a second round of appointments. That makes it an advantageous vaccine for rural areas and other hard-to-reach communities, and for distribution to community health centres and doctors surgeries that might not have the freezers needed for the other vaccines.
Johnson & Johnson officials have pledged to provide the United States with 100 million doses by the end of June. That will be combined the 600 million doses from the two-shot vaccines made by Pfizer-BioNTech and Moderna that are scheduled to arrive by the end of July. That should be more than enough shots to cover any U.S. adult who wants a vaccine, according to medical professionals.
It is the 3rd vaccine that has received the FDA’s authorisation and also the 1st single-dose vaccine available in the country
Thank you for taking the time to read this news article “FDA Grants Emergency Use Authorisation For Johnson & Johnson’s 1-Shot COVID-19 Vaccine”. For more UK daily news, Spanish daily news and Global news stories, visit the Euro Weekly News home page.
Share this story
Subscribe to our Euro Weekly News alerts to get the latest stories into your inbox!
By signing up, you will create a Euro Weekly News account if you don't already have one. Review our Privacy Policy for more information about our privacy practices.
Share your story with us by emailing newsdesk@euroweeklynews.com, by calling +34 951 38 61 61 or by messaging our Facebook page www.facebook.com/EuroWeeklyNews
By signing up, you will create a Euro Weekly News account if you don’t already have one. Review our Privacy Policy for more information about our privacy practices.
Download our media pack in either English or Spanish.